A study conducted by researchers from Boston University showed that resolvins, a family of compounds from docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may restore gums back to health and cure periodontal disease inflammation.
According to a news release from the International & American Association for Dental Research, the two omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid, control blood triglycerides and limit the development of atherosclerosis, an inflammation on the artery walls caused by too much fatty deposits. Because of their ability to reduce inflammations, these two acids are likewise very useful to people suffering from other inflammatory conditions such as Crohn’s disease, an inflammatory disease in any part of the gastrointestinal tract; and rheumatoid arthritis, the inflammation of marked deformities and joints.
The resolvins derived from docosahexaenoic acid are the D series (RvD1), and the resolvins derived from eicosapentaenoic acid are the E series (RvE1). A previous study revealed that E series resolvins (RvE1) did not only provide protection against loss of bone and soft tissue, which were associated with gum disease, but also restored lost bone and soft tissue back to healthy levels.
In the new study from Boston University, the researchers applied P. gingivalis, the gum disease-causing bacteria in humans, to rabbits. Thereafter, they treated the rabbits with D series resolvins (RvD1) and the results were beneficial.
In an interview, the association stated that the results of the study from Boston University supports the hypothesis of the researchers that both the docosahexaenoic acid-derived resolvins and eicosapentaenoic acid-derived resolvins are capable of bringing back periodontal health, by putting an end to the inflammation problem.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
Tags: fatty acid, gum disease, omega-3, omega3